In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
Title:
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
Journal:
Br J Cancer
Publication Id:
17453001
Volume:
96
Number:
10
Pages:
1587-94
year:
2007
Month:
May
Status:
published More like this
- The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.
- The epigenome as a therapeutic target in prostate cancer.
- Creating a Bio-Resource Information System for Prostate Cancer in Ireland
- Reverse engineering cellular networks with ARACNE
- 2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer.